for inclusion – Page 19 – Communicable Diseases Research

Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection

Research

Published on 2020-09-152022-10-30
Journal: Journal of Translational Medicine [Category] COVID-19, SARS,

Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region

Research Article

Published on 2020-09-092022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

[키워드] 24 hour 95% CI adjusted hazard ratio Admission age AHRF Care Cohort component Corticosteroid COVID-19 death Direct discharge evaluate the effect Final Follow-up for inclusion hospital Hospitalized hypoxemic hypoxic ICU In-hospital death in-hospital mortality intubation laboratory-confirmed men New York non-ICU non-ICU patient objective outcome outcomes PaO Patient patients patients with COVID-19 Pneumonia Primary outcome Respiratory failure Result retrospective cohort study risk screened secondary significantly lower single-center systemic corticosteroid therapeutic transfer treated Treatment were excluded with COVID-19
[DOI] 10.1371/journal.pone.0238827 PMC 바로가기 [Article Type] Research Article

The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis

Research Article

Published on 2020-09-082022-10-29
Journal: Pulmonary Medicine [Category] COVID-19, MERS, SARS,

Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study

Research Article

Published on 2020-09-082022-10-29
Journal: PLoS Medicine [Category] COVID-19, SARS,

[키워드] 30-Day mortality 95% CI acute respiratory syndrome Admission Adverse adverse outcome age analyses anti-inflammatory drug association cohort study Comorbidities concern conducted coronavirus coronavirus disease Course COVID-19 COVID-19 patients defined died drugs early phase eligible European female fevers for inclusion groups Health Hospitalization Hospitalized ICU ICU admission individual Infection intensive care limitation mechanical ventilation median age Mortality non-steroidal anti-inflammatory drug NSAID NSAIDS outcome Pain pandemic Patient PCR-positive individual population-based cohort positive raised reduce renal replacement therapy researcher residual confounding risk risk of COVID-19 risk ratio RRs SARS-CoV-2 SARS-COV-2 infection secondary selected severe coronavirus disease severe COVID-19 Sex Side effects study cohort Symptom tested the SARS-CoV-2 treat Treatment union
[DOI] 10.1371/journal.pmed.1003308 PMC 바로가기 [Article Type] Research Article

Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial

COVID-19 질병으로 고통받는 중환자의 기계적 환기에 대한 항응고, The ANTI-CO 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-09-072022-08-13
Journal: Trials [Category] SARS, 임상,

[키워드] 1:1 Abnormalities Administered allergic Anti-Co trial Anticoagulant anticoagulation anticoagulation treatment approval aPTT assumed attending physicians bivalirudin blinded Blinding Clinical improvement Coagulation comparator control group Controlled trial Corporation COVID-19 COVID-19 disease Critically ill patient D-dimer D-dimers dissemination distress dose dropout drug element eligibility eligible exclusion criteria expected experimental group FiO2 for inclusion groups heparin ICU IMPROVE include Inclusion inclusion criteria intervention group intravenously Invasive mechanical ventilation limit Local mechanical ventilation normally distributed number objective on mechanical ventilation outcome P/F P/F ratio PaO2 paO2/fiO2 parallel group parameter participant Patient patients patients with COVID-19 performed Physicians positive power power of 80% Pregnancy Primary outcome protocol randomised randomised controlled trial randomization Randomized receive recruitment Registered registration number respiratory distress Respiratory failure Sample size sample size calculation screened standard treatment status study drug Study protocol subcutaneously subject Taking the mean the patient thrombosis title treated Treatment treatment group Trial registration website
[DOI] 10.1186/s13063-020-04689-1 PMC 바로가기 [Article Type] Letter

The immune system and COVID-19: Friend or foe?

Review article

Published on 2020-09-012022-10-05
Journal: Life sciences [Category] SARS, 유전자 메커니즘,

Evaluating Trends in COVID-19 Research Activity in Early 2020: The Creation and Utilization of a Novel Open-Access Database

Epidemiology/Public Health

Published on 2020-08-222022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] Abstract accompanied activity acute respiratory syndrome Analysis article Care Case report clinical setting conducted coronavirus coronavirus disease COVID-19 COVID-19 pandemic COVID-19 research covidreview creation criteria demonstrated determine directive Evaluating Evidence exclusion for inclusion Healthcare system increase in infection control information management material measure novel pandemic pathogen patients physician platform Randomized controlled trial remained Research researcher Result SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 Spread systematic reviews Treatment trend trends utilization Volume was performed website were excluded
[DOI] 10.7759/cureus.9943 PMC 바로가기 [Article Type] Epidemiology/Public Health

Effect of an E-Learning Module on Personal Protective Equipment Proficiency Among Prehospital Personnel: Web-Based Randomized Controlled Trial

병원 전 직원의 개인 보호 장비 숙련도에 대한 E-Learning 모듈의 효과: 웹 기반 무작위 대조 시험

Original Paper

Published on 2020-08-212022-08-13
Journal: Journal of Medical Internet Research [Category] MERS, 임상,

[키워드] added All participant All participants baseline both groups Care communication confidence Contamination control group Controlled coronavirus coronavirus disease COVID-19 demonstration donning sequence e-learning group e-learning module Effect effective effective communication electronic learning eligible email equipment evaluate for inclusion gamified gamified e-learning module groups Health Health care IMPROVE in both group infection control Infection control guidelines Intervention investigators IQR knowledge misuse module no significant difference objective online learning outcome assessors pandemic participant Participants Personal protective equipment PPE prehospital preintervention proportion protection Randomized Randomized controlled trial Result risk Safety second set shown significantly statistically significant Switzerland the median Trial web-based study Work environment
[DOI] 10.2196/21265 PMC 바로가기 [Article Type] Original Paper

A systematic review of trial registry entries for randomized clinical trials investigating COVID-19 medical prevention and treatment

Research Article

Published on 2020-08-202022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

Natural Language Processing for Rapid Response to Emergent Diseases: Case Study of Calcium Channel Blockers and Hypertension in the COVID-19 Pandemic

Original Paper

Published on 2020-08-142022-10-30
Journal: Journal of Medical Internet Research [Category] Coronavirus, MERS,

[키워드] added adjusted hazard ratio baseline blocker blood pressure calcium channel coronavirus disease COVID-19 COVID-19 infection detectable disease domain Effect EHR Electronic health record Electronic health records emergent disease Epidemic evaluate for inclusion Hospital stay hospitals in-hospital mortality Infection informatics information knowledge language long-term treatment medication medication information multicenter natural natural language processing objective outcome pandemic Patient patients with COVID-19 performed phenotypic positive processing public health Rapid real time response Result Sample size Statistical power statistically suggested text mining treatment effect was obtained was used
[DOI] 10.2196/20773 PMC 바로가기 [Article Type] Original Paper